NCT00061516View on ClinicalTrials.gov

Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

BETAXON (levobetaxolol HCl)

levobetaxolol suspension, 0.5%

DRUG

AZOPT (brinzolamide)

brinzolamide suspension, 1%

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY